🇺🇸 FDA
Patent

US 11384350

Cytotoxic molecules responsive to intracellular ligands for selective T cell mediated killing

granted A61KA61K35/17A61K38/482

Quick answer

US patent 11384350 (Cytotoxic molecules responsive to intracellular ligands for selective T cell mediated killing) held by The Regents of the University of California expires Mon Jul 07 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Jul 12 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 07 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
12
CPC classes
A61K, A61K35/17, A61K38/482